Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;2(4):475-84.
doi: 10.1177/1947601911413466.

Li-fraumeni syndrome

David Malkin  1
Affiliations

Li-fraumeni syndrome

David Malkin. Genes Cancer. 2011 Apr.

Abstract

Li-Fraumeni syndrome (LFS) is a classic cancer predisposition disorder that is commonly associated with germline mutations of the p53 tumor suppressor gene. Examination of the wide spectrum of adult-onset and childhood cancers and the distribution of p53 mutations has led to a greater understanding of cancer genotype-phenotype correlations. However, the complex LFS phenotype is not readily explained by the simple identification of germline p53 mutations in affected individuals. Recent work has identified genetic events that modify the LFS phenotype. These include intragenic polymorphisms, mutations/polymorphisms of genes in the p53 regulatory pathway, as well as more global events such as aberrant copy number variation and telomere attrition. These genetic events may, in part, explain the breadth of tumor histiotypes within and across LFS families, the apparent accelerated age of onset within families, and the range of clinical outcomes among affected family members. This review will examine the clinical and genetic definitions of LFS and offer insight into how lessons learned from the study of this rare disorder may inform similar questions in other familial cancer syndromes.

Keywords: Li-Fraumeni syndrome; cancer predisposition; germline p53 mutations.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Pedigree of a family with Li-Fraumeni syndrome. Filled circles/squares represent affected members; slashes represent deceased family members. Numbers represent age at diagnosis. BB = bilateral breast cancer; CNS = brain tumor; BR = unilateral breast cancer; LK = leukemia; CPC = choroid plexus carcinoma; RMS = rhabdomyosarcoma; OS = osteosarcoma.
Figure 2.
Figure 2.
Relative frequency of germline mutations in p53 by codon adjacent to the primary structure of the p53 protein. TAD = transactivation domain; PRR = proline-rich region; DBD = DNA binding domain; TET = tetramerization domain; REG = regulatory domain. Adapted from the International Association for Research on Cancer (IARC) database (Revision 14, November 2009).
See this image and copyright information in PMC

References

    1. Li FP, Fraumeni JF., Jr Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Intern Med. 1969;71:747-52 - PubMed
    1. Li FP, Fraumeni JF., Jr Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst. 1969;43:1365-73 - PubMed
    1. Li FP, Fraumeni JF, Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988;48(18):5358-62 - PubMed
    1. Nichols KE, Malkin D, Garber JE, Fraumeni JF, Jr, Li FP. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev. 2001;10:83-7 - PubMed
    1. Birch JM, Hartley AL, Tricker KJ, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994;54:1298-304 - PubMed